All Inventions from NCATS

  • Pyruvate Kinase M2 Activators for the Treatment of Cancer
    •
       Ref: E-298-2011-1 | Updated: May 7, 2018 | NCATS
  • Novel Tocopherol and Tocopheryl Quinone Derivatives as Therapeutics for Lysosomal Storage Disorders
    •
       Ref: E-148-2012-0 | Updated: Mar 22, 2018 | NCATS
  • Substituted Quinoline Analogs as Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors
    •
       Ref: E-101-2017-0 | Updated: Feb 27, 2018 | NCATS
  • Derivatives of Docosahexaenoylethanolamide (DEA) for Neurogenesis
    •
       Ref: E-070-2012-0 | Updated: Nov 1, 2017 | NCATS
  • Novel Dopamine D2 Receptor Antagonists and Methods of Their Use
    •
       Ref: E-030-2013-0 | Updated: Sep 5, 2017 | NCATS
  • Potent and Selective Cyclic Peptide Inhibitors of Phosphoglycerate Mutase as Anti-Infective Agents
    •
       Ref: E-229-2016-0 | Updated: Apr 26, 2017 | NCATS
  • Non-toxic Compounds that Inhibit the Formation and Spreading of Tumors
    •
       Ref: E-276-2011-0 | Updated: Apr 21, 2016 | NCATS
  • Small-Molecule Inhibitors of Human Galactokinase for the Treatment of Galactosemia and Cancers
    •
       Ref: E-240-2011-0 | Updated: Apr 20, 2016 | NCATS
  • Novel Small Molecule Antimalarials for Elimination of Malaria Transmission
    •
       Ref: E-751-2013-0 | Updated: Nov 18, 2015 | NCATS
  • Selective 12-Human Lipoxygenase Inhibitors for the Treatment of Diabetes and Clotting
    •
       Ref: E-134-2010-0 | Updated: Nov 18, 2015 | NCATS
  • Cyclodextrins as Therapeutics for Lysosomal Storage Disorders
    •
       Ref: E-050-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Novel Small Molecule Agonists of the Relaxin Receptor as Potential Therapy for Heart Failure and Fibrosis
    •
       Ref: E-072-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Highly Potent and Selective Deubiquitinating Enzyme Inhibitor
    •
       Ref: E-043-2013-0 | Updated: Nov 18, 2015 | NCATS
  • Cotranslational Protein Expression System for High-throughput Screening
    •
       Ref: E-300-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Pyruvate Kinase M2 Activators for the Treatment of Cancer
    •
       Ref: E-120-2010-0 | Updated: Mar 12, 2015 | NCATS
  • Methods of Treating Giardiasis Using FDA-Approved Compounds
    •
       Ref: E-211-2010-1 | Updated: Aug 17, 2012 | NCATS
  • Glucocerebrosidase Activators as a Treatment for Gaucher Disease
    •
       Ref: E-257-2010-0 | Updated: Oct 6, 2011 | NCATS
  • Novel Small Molecule Inhibitors for the Treatment of Huntington’s Disease
    •
       Ref: E-258-2010-0 | Updated: Jun 8, 2011 | NCATS
  • Caspase Inhibitors Useful for the Study of Autoimmune or Inflammatory Diseases
    •
       Ref: E-308-2009-0 | Updated: Mar 11, 2010 | NCATS
  • Small Molecule Activators of Human Pyruvate Kinase for Treatment of Cancer and Enzyme-Deficient Hemolytic Anemia...
    •
       Ref: E-326-2008-0 | Updated: May 5, 2009 | NCATS

    Displaying 1 - 20 of 20

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057